tiprankstipranks
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market
ASBP
Aspire Biopharma Holdings
RESEARCH TOOLSreports

Aspire Biopharma Holdings (ASBP) Ratios

196 Followers

Aspire Biopharma Holdings Ratios

ASBP's free cash flow for Q1 2026 was $0.20. For the 2026 fiscal year, ASBP's free cash flow was decreased by $ and operating cash flow was $-58.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.26 0.17 0.09 0.20 3.62
Quick Ratio
 2.14 0.14 0.09 0.20 3.62
Cash Ratio
 1.86 0.13 <0.01 0.00 1.64
Solvency Ratio
 -3.00 -3.18 -7.43 14.39 0.30
Operating Cash Flow Ratio
 -1.97 -0.65 -0.16 -1.62 -4.64
Short-Term Operating Cash Flow Coverage
 -12.44 -3.56 -0.21 -52.74 -50.37
Net Current Asset Value
$ 3.87M$ -6.38M$ -1.54M$ -322.11K$ -10.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 1.06 8.56 <0.01 <0.01
Debt-to-Equity Ratio
 0.13 -0.22 -0.82 <0.01 <0.01
Debt-to-Capital Ratio
 0.11 -0.28 -4.64 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.84 -0.21 -0.10 1.02 1.04
Debt Service Coverage Ratio
 -0.32 -1.95 -31.07 271.85 119.41
Interest Coverage Ratio
 -0.55 -2.27 3.46 -149.45 0.00
Debt to Market Cap
 0.79 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 65.97 6.63 0.54 <0.01 <0.01
Net Debt to EBITDA
 1.62 -0.02 -0.11 <0.01 -0.14
Profitability Margins
Gross Profit Margin
16.30%-1.87%0.00%0.00%0.00%
EBIT Margin
-15394.09%-312016.95%0.00%0.00%0.00%
EBITDA Margin
-9544.84%-312016.95%0.00%0.00%0.00%
Operating Profit Margin
-15745.85%-312016.95%0.00%0.00%0.00%
Pretax Profit Margin
-34039.68%-394725.06%0.00%0.00%0.00%
Net Profit Margin
-34039.68%-394725.06%0.00%0.00%0.00%
Continuous Operations Profit Margin
-34039.68%-394725.06%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
216.18%126.51%405.90%-333.13%-342.09%
Return on Assets (ROA)
-165.27%-1865.68%-8471.58%22.34%1.11%
Return on Equity (ROE)
199.43%383.93%814.04%22.80%1.16%
Return on Capital Employed (ROCE)
-137.24%308.11%200.55%-6.84%-0.33%
Return on Invested Capital (ROIC)
-121.89%395.26%-48.30%-6.84%-0.33%
Return on Tangible Assets
-165.27%-1865.68%-8471.58%22.34%1.11%
Earnings Yield
-1367.40%-10.34%-0.13%0.01%<0.01%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.03 <0.01 0.00 0.00 0.00
Inventory Turnover
 0.08 0.02 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 <0.01 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.03 >-0.01 0.00 0.00 0.00
Cash Conversion Cycle
 -6.16K -43.98K 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 4.67K 14.63K 0.00 0.00 0.00
Days of Payables Outstanding
 10.83K 58.60K 0.00 0.00 0.00
Operating Cycle
 4.67K 14.63K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -39.64 -3.29 -0.38 >-0.01 -0.01
Free Cash Flow Per Share
 -39.64 -3.29 -0.38 >-0.01 -0.01
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -217.70K -352.20K
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -217.70K -352.20K
Operating Cash Flow Coverage Ratio
 -12.44 -3.56 -0.21 -52.74 -50.37
Operating Cash Flow to Sales Ratio
 -179.73 -793.85 0.00 0.00 0.00
Free Cash Flow Yield
-980.51%-2.08%>-0.01%>-0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.07 -9.67 -759.42 7.49K 15.63K
Price-to-Sales (P/S) Ratio
 18.33 38.18K 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.22 -37.14 -6.18K 1.71K 180.63
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.10 -48.10 -35.90K -51.17K -37.06K
Price-to-Operating Cash Flow Ratio
 -0.14 -48.10 -35.90K -51.17K -37.06K
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.98 2.57 68.62 -5.62
Price-to-Fair Value
 0.22 -37.14 -6.18K 1.71K 180.63
Enterprise Value Multiple
 1.43 -12.26 -817.64 5.76K 15.63K
Enterprise Value
 -4.72M 237.18M 9.52B 33.42B 52.21B
EV to EBITDA
 1.43 -12.26 -817.64 5.76K 15.63K
EV to Sales
 -136.72 38.24K 0.00 0.00 0.00
EV to Free Cash Flow
 0.76 -48.17 -35.91K -51.17K -37.06K
EV to Operating Cash Flow
 0.76 -48.17 -35.91K -51.17K -37.06K
Tangible Book Value Per Share
 24.69 -4.27 -2.23 0.26 2.28
Shareholders’ Equity Per Share
 24.69 -4.27 -2.23 0.26 2.28
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 >-0.01 0.00 <0.01
Revenue Per Share
 0.22 <0.01 0.00 0.00 0.00
Net Income Per Share
 -75.07 -16.38 -18.17 0.06 0.03
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 2.21 1.27 1.08 1.00 1.00
Research & Development to Revenue
 27.71 148.97 0.00 0.00 0.00
SG&A to Revenue
 129.91 2.97K 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.39 2.28K 0.00 0.00 0.00
Income Quality
 0.53 0.20 0.20 -0.15 -0.42
Currency in USD